Benign Prostatic Hyperplasia

Benign prostatic hyperplasia (BPH) is a noncancerous enlargement of the prostate that becomes increasingly common with age. As the prostate grows around the urethra, it can contribute to lower urinary tract symptoms such as weak stream, hesitancy, incomplete emptying, urinary frequency, urgency, and nocturia. Symptom burden does not always match prostate size exactly, which is one reason treatment decisions vary from person to person.

In Western medicine, BPH is often approached as a combination of prostate enlargement, bladder outlet resistance, and sometimes altered bladder function. This leads to options ranging from watchful waiting and medication to procedural or surgical treatment when symptoms are more disruptive or complications arise. In Eastern medicine, prostate and urinary symptoms may be interpreted through broader patterns involving aging, fluid metabolism, pelvic tension, inflammation, or kidney/bladder system imbalance, and therapies often focus on symptom regulation and quality of life.

Because BPH exists on a spectrum, treatment choice often depends on symptom severity, duration, tolerance for medication side effects or procedures, and how urgently relief is needed. It is also important to distinguish uncomplicated BPH from other causes of urinary symptoms such as urinary tract infection, prostatitis, overactive bladder, urethral stricture, neurologic conditions, or prostate cancer. A balanced decision brief can help patients compare evidence, tradeoffs, and fit across both conventional and traditional approaches.